Curexo Inc. (KOSDAQ:060280)
12,960
-740 (-5.40%)
Dec 30, 2025, 3:30 PM KST
Curexo Market Cap
Curexo has a market cap or net worth of 532.53 billion as of December 30, 2025. Its market cap has increased by 73.26% in one year.
Market Cap
532.53B
Enterprise Value
508.10B
Revenue
27.85B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,960.00
Market Cap Chart
Since November 3, 2004, Curexo's market cap has increased from 3.98B to 532.53B, an increase of 13,271.66%. That is a compound annual growth rate of 26.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 562.93B | 112.07% |
| Dec 30, 2024 | 265.44B | -65.17% |
| Dec 28, 2023 | 762.19B | 191.52% |
| Dec 29, 2022 | 261.46B | 5.49% |
| Dec 30, 2021 | 247.86B | 18.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.45T |